Novel psychoactive substances: First international conference

Human Psychopharmacology

Volumn 28, Issue 4, 2013, Pages 287-288

  Corazza, Ornella ^a   Schifano, Fabrizio ^a   Parrott, Andrew C ^b  

^a UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^b SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4' METHYLMETHCATHINONE; CANNABIS; CATHINONE; METHYLONE; PHENETHYLAMINE DERIVATIVE; PSYCHOTROPIC AGENT; RECREATIONAL DRUG;

EDITORIAL; EVOKED RESPONSE; HUMAN; INFORMATION DISSEMINATION; MEMORY; NEUROIMAGING; PRIORITY JOURNAL; RESEARCH; SUBSTANCE ABUSE;

EID: 84880772928     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2344     Document Type: Editorial

References (12)

1. Caudevilla-Gálligo F, Ventura M, Indave Ruiz BI, Fornís I,. 2013. Presence and composition of cathinone derivatives in drug samples taken from a drug test service in Spain (2010-2012). Hum Psychopharmacol Clin Exp 28: 341-344.
2. Corazza O, Assi S, Simonato P, et al,. 2013. Promoting innovation and excellence to face the rapid diffusion of novel psychoactive substances in the EU: the outcomes of the ReDNet project. Hum Psychopharmacol Clin Exp 28: 317-323.
3. Corkery JM, Elliott S, Schifano F, Corazza O, Ghodse AH,. 2013. MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5Hcyclopenta[f][1,3]benzodioxol- 6-amine; 'sparkle'; 'mindy') toxicity: a brief overview and update. Hum Psychopharmacol Clin Exp 28: 345-355.
4. Fauzi FM, Koutsoukas A, Cunningham A, Gallegos A, Sedefov R, Bender A,. 2013. Computer-aided (in silico) approaches in the mode-of-action analysis and safety assessment of Ostarine and 4-methylamphetamine. Hum Psychopharmacol Clin Exp 28: 365-378.
5. González D, Ventura M, Caudevilla F, Torrens M, Farre M,. 2013. Consumption of new psychoactive substances in a Spanish sample of research chemical users. Hum Psychopharmacol Clin Exp 28: 332-340.
6. Jebadurai J, Schifano F, Deluca P,. 2013. Recreational use of 1-(2-naphthyl)-2-(1-pyrrolidinyl)-1-pentanone hydrochloride (NRG-1), 6-(2 aminopropyl) benzofuran (Benzofury/6-APB) and NRG-2 with review of available evidence-based literature. Hum Psychopharmacol Clin Exp 28: 356-364.
7. Kaitánpy-Fövény M, Kertész M, Winstock A, et al,. 2013. Substitutional potential of mephedrone: an analysis of the subjective effects. Hum Psychopharmacol Clin Exp 28: 308-316.
8. Papanti D, Schifano F, Botteon G, et al,. 2013. "Spiceophrenia" : a systematic overview of "spice"-related psychopathological issues and a case report. Hum Psychopharmacol Clin Exp 28: 379-389.
9. Parrott AC,. 2013 Human psychobiology of MDMA or 'ecstasy': an overview of 25 years of empirical research. Hum Psychopharmacol Clin Exp 28: 289-307.
10. Simonato P, Corazza O, Santonastaso P, et al,. 2013. Novel psychoactive substances as a novel challenge for health professionals: results from an Italian survey. Hum Psychopharmacol Clin Exp 28: 324-331.
11. St John-Smith P, McQueen D, Edwards L, Schifano F,. 2013. Classical and novel psychoactive substances: rethinking drug misuse from an evolutionary psychiatric perspective. Hum Psychopharmacol Clin Exp 28: 394-401.
12. Winstock AR, Barratt MJ,. 2013. The 12-month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid products. Hum Psychopharmacol Clin Exp 28: 390-393.